Noopept

Noopept is a dipeptide-derived nootropic that raises BDNF and NGF expression, and the community runs it mostly for cognitive enhancement and focus, with smaller threads on memory and information processing and on mood and anxiety. Reported doses center on 10 mg a day, spanning 100 mcg to 50 mg, though most posters don't state a schedule. A single report notes a positive effect on sleep and dreams; there isn't enough beyond that to call any side effect a pattern. The one caveat to carry in: there's no FDA-approved indication, so all human use is off-label or compounded.

Half-life~1 h

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsPrice0.43.43.14.0

Measured on 4 of 6 axes

Research Evidence

Evidence shape

Noopept currently lacks human clinical evidence, as all existing research is restricted to animal models and preclinical mechanistic studies. There are no registered human trials, meaning the peptide has not been evaluated for safety or efficacy in clinical settings. Because the literature is entirely confined to laboratory research, there is no data to support its use for any specific indication in humans.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth15 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
3
HighMediumLow

Anecdotal efficacy

Noopept side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

Full buying guide →
1
Soma Chems
USA
500 mg
$39.99
$0.08/mg
2
Disguisedalpha
US
102 mg
$39.99
$0.392/mg
3
Top Peptide
--
20 mg
$22.99
$1.15/mg
4
Peptide Pros
--
20 mg
$25.25
$1.26/mg
5
Nootropic Source
USA
1.5 mg
$5.50
$3.67/mg

price offers can be sorted by column

Noopept dosing & protocol

How Noopept is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
—
0
10 mg
20 mg
30 mg
40 mg
50 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
—
0
10 mg
20 mg
30 mg
40 mg
50 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 15
Typical dose
10 mg100 µg – 50 mg
typical
0
10 mg
20 mg
30 mg
40 mg
50 mg
distribution of 16 reported doses · darker = more
Frequency
unspecified
Route
oral

Across 15 community reports, oral doses cluster around 10–30 mg, with a handful reporting much lower amounts — 100–250 mcg — via nasal spray. Frequency wasn't captured in these reports, and no cycling patterns were noted.

15 sources

Related peptides

SelankSemaxDihexaP21NSI-189AdamaxPE 22-28Cerebrolysin